Home/Filings/4/0001493152-23-033068
4//SEC Filing

Jafri Hasan 4

Accession 0001493152-23-033068

CIK 0001614067other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 4:05 PM ET

Size

5.2 KB

Accession

0001493152-23-033068

Insider Transaction Report

Form 4
Period: 2023-09-18
Jafri Hasan
Chief Medical Officer
Transactions
  • Award

    Stock Options

    2023-09-18+20,000175,000 total
    Exercise: $0.08Exp: 2033-09-18Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]50% of the options vest on the date of grant and approximately 1,666 vest on a monthly basis thereafter for six months.

Documents

1 file

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1
  • filerCIK 0001815352

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:05 PM ET
Size
5.2 KB